| 1. |
- Cameron, Adrian J., et al.
(författare)
-
Combined Influence of Waist and Hip Circumference on Risk of Death in a Large Cohort of European and Australian Adults
- 2020
-
Ingår i: Journal of the American Heart Association. - : John Wiley & Sons. - 2047-9980. ; 9:13
-
Tidskriftsartikel (refereegranskat)abstract
- Background: Waist circumference and hip circumference are both strongly associated with risk of death; however, their joint association has rarely been investigated.Methods and Results: The MONICA Risk, Genetics, Archiving, and Monograph (MORGAM) Project was conducted in 30 cohorts from 11 countries; 90 487 men and women, aged 30 to 74 years, predominantly white, with no history of cardiovascular disease, were recruited in 1986 to 2010 and followed up for up to 24 years. Hazard ratios were estimated using sex‐specific Cox models, stratified by cohort, with age as the time scale. Models included baseline categorical obesity measures, age, total and high‐density lipoprotein cholesterol, systolic blood pressure, antihypertensive drugs, smoking, and diabetes mellitus. A total of 9105 all‐cause deaths were recorded during a median follow‐up of 10 years. Hazard ratios for all‐cause death presented J‐ or U‐shaped associations with most obesity measures. With waist and hip circumference included in the same model, for all hip sizes, having a smaller waist was strongly associated with lower risk of death, except for men with the smallest hips. In addition, among those with smaller waists, hip size was strongly negatively associated with risk of death, with ≈20% more people identified as being at increased risk compared with waist circumference alone.Conclusions: A more complex relationship between hip circumference, waist circumference, and risk of death is revealed when both measures are considered simultaneously. This is particularly true for individuals with smaller waists, where having larger hips was protective. Considering both waist and hip circumference in the clinical setting could help to best identify those at increased risk of death.
|
|
| 2. |
- Hesketh, Kylie D., et al.
(författare)
-
Protocol for the Lets Grow randomised controlled trial : examining efficacy, cost-effectiveness and scalability of a m-Health intervention for movement behaviours in toddlers
- 2022
-
Ingår i: BMJ Open. - : BMJ Publishing Group. - 2044-6055. ; 12:3
-
Tidskriftsartikel (refereegranskat)abstract
- Introduction Despite being an important period for the development of movement behaviours (physical activity, sedentary behaviour and sleep), few interventions commencing prior to preschool have been trialled. The primary aim of this trial is to assess the 12-month efficacy of the Lets Grow mHealth intervention, designed to improve the composition of movement behaviours in children from 2 years of age. Lets Grow is novel in considering composition of movement behaviours as the primary outcome, using non-linear dynamical approaches for intervention delivery, and incorporating planning for real-world implementation and scale-up from its inception. Methods and analysis A randomised controlled trial will test the effects of the 12-month parental support mHealth intervention, Lets Grow, compared with a control group that will receive usual care plus electronic newsletters on unrelated topics for cohort retention. Lets Grow will be delivered via a purpose-designed mobile web application with linked SMS notifications. Intervention content includes general and movement-behaviour specific parenting advice and incorporates established behaviour change techniques. Intervention adherence will be monitored by app usage data. Data will be collected from participants using 24-hour monitoring of movement behaviours and parent report at baseline (T-0), mid-intervention (T-1; 6 months post baseline), at intervention conclusion (T-2; 12 months post baseline) and 1-year post intervention (T-3; 2 years post baseline). The trial aims to recruit 1100 families from across Australia during 2021. In addition to assessment of efficacy, an economic evaluation and prospective scalability evaluation will be conducted. Ethics and dissemination The study was approved by the Deakin University Human Ethics Committee (2020-077). Study findings will be disseminated through publication in peer-reviewed journals, presentation at scientific and professional conferences, and via social and traditional media.
|
|
